We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GCTS:NYSEGCT Semiconductor Holding, Inc. Analysis

Data as of 2026-06-13 - not real-time

$2.52

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GCT Semiconductor (GCTS) is trading at $2.52, which sits below its 20‑day SMA of $2.96 but above the 50‑day ($2.01) and 200‑day ($1.49) averages, indicating mixed short‑term momentum within a longer‑term uptrend. The RSI of 48.9 suggests the stock is neither overbought nor oversold, while the MACD histogram is negative and the signal line is bearish, reinforcing a cautious near‑term outlook. Volume has been decreasing and 30‑day volatility is extreme at 174%, highlighting heightened price swings and liquidity concerns. On the fundamentals side, the company reported a staggering 287% YoY revenue surge to $1.9 million in Q1 2026, driven by a 58% sequential jump in 5G chipset shipments, yet it still posts a negative gross margin (‑22%) and operating loss (‑3.2%), with a massive negative EBITDA of $34 million and a cash deficit (cash $7.2 M vs debt $58.2 M). The balance sheet weakness is underscored by a negative price‑to‑book ratio (‑2.47) and a sky‑high price‑to‑sales multiple of 48.8, while the forward PE of ‑72 signals that earnings are expected to remain negative.
The recent strategic partnership with MaxLinear to co‑develop next‑generation 5G fixed‑wireless access gateways adds a credible growth catalyst, potentially expanding market reach and improving future margins. However, the company’s high debt load, ongoing cash burn, and a historical max drawdown of ‑43.7% keep the risk profile elevated. Given the “Extreme Greed” sentiment index (89.86) and an upside potential of ~38% versus downside risk, the stock sits at a speculative inflection point where upside hinges on execution of the 5G roadmap and improvement in profitability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and decreasing volume
  • Price below 20‑day SMA
  • Recent partnership provides near‑term catalyst but earnings remain negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • 287% YoY revenue growth and 58% sequential 5G shipment increase
  • Strategic MaxLinear partnership expanding product addressable market
  • Longer‑term uptrend confirmed by SMA50 and SMA200 positioning

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Fundamental weakness: negative margins, high debt, cash burn
  • Potential for 5G market expansion if execution succeeds
  • Elevated volatility and historical drawdown keep risk elevated

Key Metrics & Analysis

Financial Health

Revenue Growth287.10%
P/E Ratio-72.0
ROA-109.56%
P/B Ratio-2.5
Op. Cash Flow$-30153000
Free Cash Flow$-16696625
Industry P/E36.8

Technical Analysis

TrendBullish
RSI48.9
Support$1.34
Resistance$3.93
MA 20$2.96
MA 50$2.01
MA 200$1.49
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Target Price$3.47
Upside/Downside37.57%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.96
Volatility174.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.